Durability of Response in Plaque Psoriasis Patients Treated with Certolizumab Pegol: Two Year Data from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
10-2019
Journal Title
Journal of the American Academy of Dermatology
Department
Dermatology
Recommended Citation
Gordon, K., Reich, K., Blauvelt, A., Thaci, D., Leonardi, C., Poulin, Y., Boehnlein, M., Kavanagh, S., Arendt, C., & Gottlieb, A. B. (2019). Durability of Response in Plaque Psoriasis Patients Treated with Certolizumab Pegol: Two Year Data from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. Journal of the American Academy of Dermatology, 81 (4 Suppl. 1), AB195. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/255
COinS